Trade Summary

1 week ago, WEHRWEIN SVEN, serving as Dir at AtriCure, Inc. (ATRC), sold 25,000 shares at $37.84 per share, for a total transaction value of $946,000.00. Following this transaction, WEHRWEIN SVEN now holds 40,518 shares of ATRC.

This sale represents a 38.16% decrease in WEHRWEIN SVEN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 4:57 PM ET, 2 days after the trade was made.

AtriCure, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.